Miguel A Moreno-Gonzalez

8PUBLICATIONS
13CO-AUTHORS
NanophotonicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Plant pathologyNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 23, 2026
Plant-Produced Viral Nanoparticles Decorated with Nanobodies Against HER2 Improve Retention and Recruitment of Immune Cells in Solid Tumors.

Enrique Lozano-Sanchez, Miguel A Moreno-Gonzalez, Fernando Merwaiss

|Dec 12, 2025
Virus nanoparticle intratumoral vaccines for HER2+ malignancies.

Miguel A Moreno-Gonzalez, Jessica Fernanda Affonso de Oliveira, Manuel L Penichet

|Dec 05, 2024
Combination of cowpea mosaic virus (CPMV) intratumoral therapy and oxaliplatin chemotherapy.

Miguel A Moreno-Gonzalez, Zhongchao Zhao, Adam A Caparco

|Nov 11, 2024
Plant Virus Intratumoral Immunotherapy with CPMV and PVX Elicits Durable Antitumor Immunity in a Mouse Model of Diffuse Large B-Cell Lymphoma.

Jessica Fernanda Affonso de Oliveira, Miguel A Moreno-Gonzalez, Yifeng Ma

|Nov 08, 2024
A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles.

Sweta Karan, Jessica Fernanda Affonso De Oliveira, Miguel A Moreno-Gonzalez

|Mar 28, 2022
Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate.

Christian Isalomboto Nkanga, Oscar A Ortega-Rivera, Matthew D Shin

Pageof 2